To:
(Enter e-mail address of recipient)
From:
(Enter your e-mail address)
Subject:
Comments:
(Customise the e-mail with your own comments)
  CEO's Comments - October 2001
Novogen is now undertaking a concerted program of clinical trials. This advanced development phase has commenced with th...